go to main content
Radboudumc and partners News
Results (80)

Filter results

setup e-mail alert

Setup e-mail alerts

An email has been sent. Click on the link in the email to activate your emailalert.
Something went wrong!
Something went wrong while requesting this page. Please try again.
Email address *

  • Would you like to receive e-mail updates?

    Select the frequency of how often you would like to receive an e-mail alert

Cell4Pharma successfully closed a major funding round

25 May 2023

Radboudumc spin-off Cell4Pharma is pleased to announced it has successfully closed a major funding round, marking a significant milestone in their journey towards developing ciPTEC as the leading platform to study human renal biological interaction during the preclinical stages of drug development

New approach by GlycoTherapeutics

26 April 2023

With a Vroegefasefinanciering (VFF) Gelderland, GlycoTherapeutics is looking to validate their method and further research their strategy to combat cancer.

Saving lives with a small pump inside the heart CardiacBooster

31 March 2023 Less damage to organs and a greater chance of survival after having a heart attack. That's what Radboudumc spin-off CardiacBooster is aiming to accomplish.

Strategic partnership Enzyre BV and Takeda for better diagnostics for bleeding disorders

31 March 2023 Takeda announced to have entered into a strategic partnership with Enzyre BV, a Radboudumc spin-off company.

Radboudumc and Eindhoven University of Technology join forces in BIOTRIP Biotech incubator to deliver the vaccines and immunotherapies of the future.

31 March 2023 BIOTRIP is a unique platform aimed at developing, commercializing, and making available of vaccins and immunotherapies.